Persistent remission of severe rheumatoid arthritis associated with myelodysplastic syndrome upon treatment with lenalidomide.
Joint bone spine(2024)
Abstract
•Individuals with a history of autoimmune diseases, including RA, have an increased risk of developing MDS.•Patient with long-standing, severe and refractory RA who developed MDS achieved remission of both conditions with Lenalidomide.•Lenalidomide might be an effective option for concurrent RA with MDS.
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined